| Secondary |
| Rheumatoid Arthritis |
46.6% |
| Juvenile Arthritis |
12.9% |
| Product Used For Unknown Indication |
12.6% |
| Drug Use For Unknown Indication |
11.6% |
| Psoriatic Arthropathy |
4.5% |
| Vasculitis |
4.5% |
| Polyarthritis |
2.9% |
| Ankylosing Spondylitis |
1.6% |
| Juvenile Idiopathic Arthritis |
1.1% |
| Breast Cancer Female |
0.5% |
| Antibiotic Prophylaxis |
0.3% |
| Arthritis |
0.3% |
| Epilepsy |
0.3% |
| Intervertebral Disc Disorder |
0.3% |
| Musculoskeletal Pain |
0.3% |
|
| Cervical Dysplasia |
10.3% |
| Rheumatoid Arthritis |
8.6% |
| Drug Exposure During Pregnancy |
6.9% |
| Duodenal Ulcer |
6.9% |
| Lymphomatoid Papulosis |
6.9% |
| Breast Reconstruction |
5.2% |
| Impaired Healing |
5.2% |
| Incontinence |
5.2% |
| Radiation Injury |
5.2% |
| Upper Respiratory Tract Infection |
5.2% |
| Cerebral Infarction |
3.4% |
| Hypersensitivity |
3.4% |
| Intra-abdominal Haemorrhage |
3.4% |
| Lymphocyte Count Increased |
3.4% |
| Oesophageal Adenocarcinoma |
3.4% |
| Pancytopenia |
3.4% |
| Petechiae |
3.4% |
| Pulmonary Fibrosis |
3.4% |
| Pulmonary Oedema |
3.4% |
| Renal Cell Carcinoma Stage I |
3.4% |
|
| Concomitant |
| Rheumatoid Arthritis |
46.9% |
| Juvenile Arthritis |
11.6% |
| Product Used For Unknown Indication |
9.3% |
| Polyarthritis |
8.0% |
| Psoriatic Arthropathy |
7.7% |
| Psoriasis |
3.2% |
| Osteoporosis |
1.6% |
| Ankylosing Spondylitis |
1.3% |
| Drug Use For Unknown Indication |
1.3% |
| Hypertension |
1.3% |
| Juvenile Idiopathic Arthritis |
1.3% |
| Spondylitis |
1.3% |
| Chronic Lymphocytic Leukaemia |
1.0% |
| Anti-cyclic Citrullinated Peptide Antibody |
0.6% |
| Cerebrovascular Accident Prophylaxis |
0.6% |
| Gastritis |
0.6% |
| Pain |
0.6% |
| Polymyalgia Rheumatica |
0.6% |
| Prophylaxis |
0.6% |
| Anaemia |
0.3% |
|
| Condition Aggravated |
11.1% |
| Rheumatoid Arthritis |
9.3% |
| Monoplegia |
7.4% |
| Vasculitis |
7.4% |
| Cerebrovascular Accident |
5.6% |
| Malignant Melanoma |
5.6% |
| Weight Abnormal |
5.6% |
| Brain Neoplasm |
3.7% |
| Breast Cancer |
3.7% |
| Bundle Branch Block Right |
3.7% |
| Colon Cancer Metastatic |
3.7% |
| Hypertension |
3.7% |
| Myalgia |
3.7% |
| Oesophageal Adenocarcinoma |
3.7% |
| Oropharyngeal Neoplasm |
3.7% |
| Paraesthesia |
3.7% |
| Paralysis |
3.7% |
| Prostate Cancer |
3.7% |
| Staphylococcal Infection |
3.7% |
| Swelling Face |
3.7% |
|
| Interacting |
| Arthritis |
50.0% |
| Drug Use For Unknown Indication |
25.0% |
| Yersinia Infection |
25.0% |
|
| Hepatic Enzyme Increased |
100.0% |
|
